Standout Papers

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/indepe... 2014 2026 2018 2022 439
  1. Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine (2014)
    Lawrence M. Gelbert, Shufen Cai et al. Investigational New Drugs

Immediate Impact

4 from Science/Nature 96 standout
Sub-graph 1 of 19

Citing Papers

The senescence-associated secretory phenotype and its physiological and pathological implications
2024 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
1 intermediate paper

Works of Xi Lin being referenced

Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice
2022
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
2014 Standout

Author Peers

Author Last Decade Papers Cites
Xi Lin 454 198 47 378 17 735
J. L. Formento 467 294 32 227 19 828
Stephen Castaneda 353 210 141 143 14 666
Kenneth E. Hook 338 415 32 109 15 782
Khoi Chu 464 424 67 214 21 849
John F. Herath 136 278 28 373 14 761
Claire Villalva 288 245 48 135 20 595
Shanna A. Arnold 328 223 67 93 18 752
Lucia Zanatta 174 170 16 315 18 634
Ana Teresa Amaral 200 302 60 235 19 604
Kevin McMahon 184 318 81 313 15 721

All Works

Loading papers...

Rankless by CCL
2026